| # | Drug | Count |
|---|---|---|
| 0 | LAMIVUDINE | 24 |
| 1 | LAMIVUDINE ORAL | 24 |
| 2 | ABACAVIR | 20 |
| 3 | ABACAVIR SULFATE | 20 |
| 4 | NEVIRAPINE | 12 |
| 5 | LAMIVUDINE AND ZIDOVUDINE | 8 |
| 6 | DIAZEPAM | 6 |
| 7 | DIAZEPAM ORAL | 6 |
| 8 | DIAZEPAM ORAL SOLUTION (CONCENTRATE) | 6 |
| 9 | GABAPENTIN | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ABACAVIR SULFATE | 20 | 0.0021 |
| 1 | LOXAPINE | 6 | 0.0015 |
| 2 | NEVIRAPINE | 12 | 0.0013 |
| 3 | PURIXAN | 1 | 0.0013 |
| 4 | LAMIVUDINE AND ZIDOVUDINE | 8 | 0.0010 |
| 5 | LAMIVUDINE | 24 | 0.0009 |
| 6 | RALTEGRAVIR | 3 | 0.0006 |
| 7 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 4 | 0.0005 |
| 8 | MARIBAVIR | 1 | 0.0004 |
| 9 | EFAVIRENZ | 4 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 16 | 0.0007 |
| 1 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 24 | 0.0005 |
| 2 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 1 | 0.0004 |
| 3 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 25 | 0.0002 |
| 4 | Antiparasitic [EPC] | 1 | 0.0002 |
| 5 | Pediculicide [EPC] | 1 | 0.0002 |
| 6 | Interleukin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 7 | Complement Inhibitor [EPC] | 3 | 0.0001 |
| 8 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 9 | Protease Inhibitor [EPC] | 2 | 0.0000 |